David Baltimore was a big deal in the world of science. He was born in 1938 and passed away in 2025. His work changed how we fight leukemia, a type of blood cancer. He was like an architect, but instead of buildings, he designed new ways to understand and treat diseases. Baltimore's work was all ab
Malachi, a lively toddler, loved his dinosaurs, monster trucks, and the Miami Dolphins. His mom, Meghan Jenkins, was busy with work and daycare, enjoying the hustle and bustle of life. But in March 2021, things took a worrying turn. Malachi became unusually tired, coughed a lot, and one day, threw u
A mother is fighting for answers after her daughter's untimely death. Lyndsey Sutherland is suing a health center, claiming they missed critical signs of a rare leukemia in her 15-year-old daughter, Jasmine Vincent. The trial has been emotional, with videos of Jasmine's cheerful moments playing in c
The world of blood cancers is getting more detailed. Experts are now focusing on specific gene changes to understand different types of leukemia better. One key gene, RUNX1, is causing some confusion. Some groups, like the International Consensus Classification, say RUNX1 changes are linked to a typ
Childhood leukemia is a tough nut to crack. Doctors usually rely on glucocorticoids to treat it. But what happens when these drugs stop working? That's where the search for new treatments comes in. Ivermectin, a drug known for kicking out parasites, might have a hidden talent. Scientists think it c
Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition wors
Chronic myeloid leukemia (CML) patients face a tough question after hitting remission: what's next? Doctors often lack clear guidelines for managing care at this stage. A recent study tackles this issue by creating a model to predict the risk of relapse. The model focuses on early changes in BCR::AB
B-cell acute lymphoblastic leukemia (B-ALL) is a complex disease. Scientists have been trying to understand how the origins of these cells affect how the disease behaves and how well treatments work. A recent study took a deep dive into this topic using advanced technology to analyze single cells fr
In the world of leukemia treatment, genetics are playing an increasingly important role. A recent study looked at how genetic testing can help predict outcomes for young adults with acute lymphoblastic leukemia (ALL). The study focused on patients between the ages of 16 and 39, a group that often fa
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that makes people more likely to get infections. This is due to a mix of factors related to the patient's health, the disease itself, and the treatments used. With new treatments coming out, it's crucial to figure out how these treatments affect
